Archives

  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • Cy3 TSA Fluorescence System Kit: Signal Amplification in ...

    2026-03-18

    Cy3 TSA Fluorescence System Kit: Signal Amplification in IHC & ISH

    Executive Summary: The Cy3 TSA Fluorescence System Kit (SKU: K1051) utilizes tyramide signal amplification (TSA) to boost detection sensitivity in immunohistochemistry (IHC), immunocytochemistry (ICC), and in situ hybridization (ISH) workflows [APExBIO]. The kit employs HRP-conjugated antibodies to catalyze covalent deposition of Cy3-tyramide at target sites, enabling detection of low-abundance proteins and nucleic acids [Chen et al., 2025]. The Cy3 fluorophore exhibits excitation at 550 nm and emission at 570 nm, compatible with standard fluorescence microscopes. All kit reagents are validated for stability (Cyanine 3 Tyramide: -20°C, light-protected, ≤2 years; other components: 4°C, ≤2 years). APExBIO supplies the kit for research use only, excluding diagnostic or therapeutic applications.

    Biological Rationale

    Detection of low-abundance proteins and nucleic acids is central to molecular pathology and functional genomics. Standard immunohistochemistry (IHC), immunocytochemistry (ICC), and in situ hybridization (ISH) protocols often lack sensitivity for rare targets or weakly expressed genes [Signal Amplification Redefined]. TSA-based amplification leverages enzymatic turnover to covalently deposit labeled tyramide molecules, enhancing both sensitivity and spatial resolution. The Cy3 TSA Fluorescence System Kit from APExBIO extends these benefits, providing robust detection capabilities for applications including cancer biomarker studies, neurobiology, and transcriptomics [Related Article]. This article advances prior reviews by detailing mechanistic, empirical, and workflow integration aspects of the kit.

    Mechanism of Action of Cy3 TSA Fluorescence System Kit

    Tyramide signal amplification (TSA) exploits the catalytic activity of horseradish peroxidase (HRP) conjugated to a secondary antibody. Upon addition of the Cy3-labeled tyramide substrate, HRP catalyzes the oxidation of tyramide in the presence of hydrogen peroxide (H2O2). This reaction generates a highly reactive intermediate that covalently binds to electron-rich tyrosine residues on proteins within the immediate vicinity of the enzyme [Chen et al., 2025]. The process yields a dense and localized fluorescent signal, minimizing background and maximizing target specificity. The Cy3 fluorophore is excited at 550 nm and emits at 570 nm, allowing detection on standard fluorescence filter sets. The kit's dry Cyanine 3 Tyramide must be dissolved in DMSO prior to use. All reactions are performed under ambient laboratory conditions (20–25°C) unless otherwise specified.

    Evidence & Benchmarks

    • TSA enables detection of proteins and nucleic acids at femtomole levels in fixed cells and tissues (https://doi.org/10.1016/j.jare.2025.04.029).
    • Cy3 TSA Fluorescence System Kit achieves signal amplification up to 100-fold over direct immunofluorescence in IHC and ICC protocols (https://mk-0822.com/index.php?g=Wap&m=Article&a=detail&id=15286).
    • Signal localization is restricted to HRP activity zones, ensuring subcellular spatial precision (https://amadacycline.com/index.php?g=Wap&m=Article&a=detail&id=14349).
    • Fluorescence signal is stable for months when slides are stored at 4°C, protected from light (https://www.apexbt.com/cy3-tsa-fluorescence-system-kit.html).
    • The kit has been benchmarked in studies of macrophage polarization and NLRP3 inflammasome detection in cardiovascular models (https://doi.org/10.1016/j.jare.2025.04.029).

    This article expands on previous reviews by providing updated benchmark data and clarifying the kit's utility for ultrasensitive detection in emerging research contexts.

    Applications, Limits & Misconceptions

    The Cy3 TSA Fluorescence System Kit is validated for the following applications:

    • Immunohistochemistry (IHC) on paraffin-embedded and frozen sections.
    • Immunocytochemistry (ICC) in fixed cultured cells.
    • In situ hybridization (ISH) for nucleic acid detection.
    • Detection of low-abundance targets in cancer, neuroscience, and cardiovascular research.

    It is not intended for live-cell imaging, flow cytometry, or diagnostic use. TSA is most effective in fixed, permeabilized samples where endogenous peroxidase activity has been blocked. The kit is not validated for multiplexing with other HRP-based detection systems without prior optimization.

    Common Pitfalls or Misconceptions

    • Not for live-cell imaging: The kit is validated only for fixed cells and tissue sections; live-cell protocols are incompatible due to cytotoxicity of TSA reagents.
    • Endogenous peroxidase interference: Failure to block endogenous peroxidase can yield high background; pre-treatment is essential in tissues with innate peroxidase activity.
    • Multiplexing constraints: Simultaneous detection of multiple targets using HRP-based TSA requires careful sequential staining and quenching steps to avoid cross-reactivity.
    • Not for diagnostic use: The kit is labeled for research use only and is not suitable for clinical diagnostics or therapeutic monitoring.
    • Photobleaching risk: Prolonged light exposure can reduce Cy3 fluorescence; slides should be stored protected from light.

    By specifying these boundaries, this article clarifies and updates guidance provided in earlier reviews, particularly regarding live-cell and multiplexing limitations.

    Workflow Integration & Parameters

    The Cy3 TSA Fluorescence System Kit integrates into standard IHC/ICC/ISH workflows as follows:

    1. Sample fixation (e.g., 4% paraformaldehyde, 10–20 min at RT).
    2. Permeabilization (e.g., 0.1% Triton X-100, 10 min at RT).
    3. Blocking endogenous peroxidase (e.g., 3% H2O2, 10 min at RT).
    4. Blocking reagent application (provided in kit, 30 min at RT).
    5. Primary antibody or probe incubation (as per target, 1–16 h at 4°C or RT).
    6. HRP-conjugated secondary antibody incubation (30–60 min at RT).
    7. Cy3-tyramide working solution application (prepared in amplification diluent, 10 min at RT).
    8. Washing and counterstaining (e.g., DAPI for nuclei).
    9. Mounting and fluorescence imaging (Cy3 filter: Ex 550 nm/Em 570 nm).

    Storage: Cyanine 3 Tyramide at -20°C, light-protected; Amplification Diluent and Blocking Reagent at 4°C. The kit is supplied by APExBIO and is referenced in multiple technical reviews [see here] for its robust integration into advanced workflows, especially in studies of cancer lipid metabolism where signal amplification is critical.

    Conclusion & Outlook

    The Cy3 TSA Fluorescence System Kit from APExBIO represents a validated, high-sensitivity solution for detection of low-abundance biomolecules in IHC, ICC, and ISH. Its robust HRP-catalyzed tyramide deposition mechanism enables spatially precise, stable, and bright fluorescence signals, facilitating discovery in cellular biology, pathology, and translational research. While not suited for live-cell or diagnostic applications, the kit delivers reproducible results in fixed sample workflows. Ongoing advances in multiplex TSA and fluorophore chemistry may further extend its utility in single-cell and spatial omics research. For detailed protocols and ordering information, visit the Cy3 TSA Fluorescence System Kit product page.